Home
About
FAQ
History (22)
In vitro biocompatibility evaluation of naturally derived and synthetic biomaterials using normal human bladder smooth muscle cells.
Trial of intrathecal rituximab in progressive multiple sclerosis patients with evidence of leptomeningeal contrast enhancement.
Batroxobin
Unintended Consequences: Medicare Performance Programs and Health Disparities
Peritoneal carcinomatosis: what can we do about it?
See All 22 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Peritoneal carcinomatosis: what can we do about it?
Shen P, Levine EA, Loggie BW. Peritoneal carcinomatosis: what can we do about it? J Clin Oncol. 2004 Jan 01; 22(1):202; author reply 203.
View in:
PubMed
subject areas
Antineoplastic Combined Chemotherapy Protocols
Carcinoma
Combined Modality Therapy
Humans
Hyperthermia, Induced
Infusions, Parenteral
Patient Care Planning
Patient Selection
Peritoneal Neoplasms
authors with profiles
Perry Shen MD
Edward A. Levine MD